Is a complete BCBA/CVS research report available?

No complete published report is available for bcba/CVS (BCBA/CVS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/CVS (BCBA/CVS)

Buenos Aires Stock Exchange: BCBA/CVS · ARS

ARS 10,000

-279.61 (-2.7%)· Recorded snapshot

Market cap	179.3T
Revenue (ttm)	611.3T
Net income (ttm)	7.2T
EPS (ttm)	ARS 391
P/E (trailing)	25.6x
P/E (forward)	11.1x
Dividend	ARS 188 (1.88%)
Volume	10,393

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 611.3T
Net income (ttm): 7.2T
EPS (ttm): ARS 391
P/E (trailing): 25.6x
P/E (forward): 11.1x
Market cap: 179.3T

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-11-04
Employees	300,000
Employees change	0
Employees growth	0%
Enterprise value	ARS 275.5T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1963
Industry	Healthcare Plans
Is primary listing	No
ISIN number	AR0107022060
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Market cap	ARS 179.3T
Next earnings date	2026-11-04
Price	ARS 10,000.00
Price currency	ARS
Sector	Healthcare
SIC code	8000
Stock price date	2026-10-27
Symbol	bcba/CVS
Website	https://www.cvshealth.com

Metric

Value

Amount currency

ARS

Country

United States

Country code

Earnings date

2026-11-04

Employees

300,000

Employees change

Employees growth

Enterprise value

ARS 275.5T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1963

Industry

Healthcare Plans

Is primary listing

ISIN number

AR0107022060

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Market cap

ARS 179.3T

Next earnings date

2026-11-04

Price

ARS 10,000.00

Price currency

ARS

Sector

Healthcare

SIC code

8000

Stock price date

2026-10-27

Symbol

bcba/CVS

Website

https://www.cvshealth.com

Metric	Value
Average P/E ratio (10Y)	23.26x
Average P/E ratio (3Y)	35.75x
Average P/E ratio (5Y)	30.59x
Earnings yield	3.91%
EV/Earnings	38.03x
EV/EBIT	14.73x
EV/EBITDA	9.09x
EV/FCF	15.81x
EV/Sales	0.43x
FCF / EV yield	6.32%
FCF yield	9.72%
Forward P/E	11.12x
Graham number	7747.88839
Graham upside	-22.52%
Lynch fair value	ARS 2,020.44
Lynch upside	-79.8%
P/(FCF - SBC) ratio	10.96x
P/(OCF - SBC) ratio	8.6x
P/B ratio	1.51x
P/E ratio	25.55x
P/FCF ratio	10.29x
P/OCF ratio	8.19x
P/S ratio	0.29x
Price/EBITDA ratio	7.25x

Metric

Value

Average P/E ratio (10Y)

23.26x

Average P/E ratio (3Y)

35.75x

Average P/E ratio (5Y)

30.59x

Earnings yield

3.91%

EV/Earnings

38.03x

EV/EBIT

14.73x

EV/EBITDA

9.09x

EV/FCF

15.81x

EV/Sales

0.43x

FCF / EV yield

6.32%

FCF yield

9.72%

Forward P/E

11.12x

Graham number

7747.88839

Graham upside

-22.52%

Lynch fair value

ARS 2,020.44

Lynch upside

-79.8%

P/(FCF - SBC) ratio

10.96x

P/(OCF - SBC) ratio

8.6x

P/B ratio

1.51x

P/E ratio

25.55x

P/FCF ratio

10.29x

P/OCF ratio

8.19x

P/S ratio

0.29x

Price/EBITDA ratio

7.25x

Metric	Value
EBIT margin	2.95%
EBITDA margin	4.04%
Effective tax rate	15.59%
FCF margin	2.74%
Gross margin	13.64%
Operating margin	2.95%
Pretax margin	1.4%
Profit margin	1.19%
Profit per employee	ARS 27.9M
Profitable quarters	3
Profitable years	7
Revenue per employee	ARS 2.4B
ROA	2.97%
ROA (5Y)	3.25%
ROCE	7.29%
ROE	6.21%
ROE (5Y)	7.3%
ROIC	7.17%
ROIC (5Y)	6.76%
SBC / revenue	0.17%
Tax / revenue	0.22%

Metric

Value

EBIT margin

2.95%

EBITDA margin

4.04%

Effective tax rate

15.59%

FCF margin

2.74%

Gross margin

13.64%

Operating margin

2.95%

Pretax margin

1.4%

Profit margin

1.19%

Profit per employee

ARS 27.9M

Profitable quarters

Profitable years

Revenue per employee

ARS 2.4B

ROA

2.97%

ROA (5Y)

3.25%

ROCE

7.29%

ROE

6.21%

ROE (5Y)

7.3%

ROIC

7.17%

ROIC (5Y)

6.76%

SBC / revenue

0.17%

Tax / revenue

0.22%

Metric	Value
EPS growth	6.3%
EPS growth (Q)	188.75%
EPS growth (QoQ)	0.43%
EPS growth 10Y	-1.29%
EPS growth 3Y	18.83%
EPS growth 5Y	-6.92%
EPS growth quarters	3
EPS growth years	0
FCF growth	145.98%
FCF growth (Q)	338.3%
FCF growth (QoQ)	66.29%
FCF growth 3Y	-12.7%
FCF growth 5Y	0.24%
Gross profit growth	10.11%
Gross profit growth (Q)	15.28%
Gross profit growth 3Y	1.97%
Gross profit growth 5Y	3.1%
Net income growth	7.92%
Net income growth (Q)	191.77%
Net income growth (QoQ)	1.22%
Net income growth 3Y	18.15%
Net income growth 5Y	-7.45%
Net income growth quarters	3
Net income growth years	0
OCF growth	95.3%
OCF growth (Q)	234.48%
OCF growth (QoQ)	49.33%
OCF growth 10Y	4.54%
OCF growth 3Y	-10.36%
OCF growth 5Y	0.83%
Operating income growth	30.17%
Operating income growth (Q)	47.59%
Operating income growth 3Y	-5.64%
Operating income growth 5Y	-1.43%
Revenue growth	7.37%
Revenue growth (Q)	7.14%
Revenue growth (QoQ)	5.61%
Revenue growth 10Y	9.49%
Revenue growth 3Y	6.87%
Revenue growth 5Y	8.28%
Revenue growth quarters	53
Revenue growth years	15

Metric

Value

EPS growth

6.3%

EPS growth (Q)

188.75%

EPS growth (QoQ)

0.43%

EPS growth 10Y

-1.29%

EPS growth 3Y

18.83%

EPS growth 5Y

-6.92%

EPS growth quarters

EPS growth years

FCF growth

145.98%

FCF growth (Q)

338.3%

FCF growth (QoQ)

66.29%

FCF growth 3Y

-12.7%

FCF growth 5Y

0.24%

Gross profit growth

10.11%

Gross profit growth (Q)

15.28%

Gross profit growth 3Y

1.97%

Gross profit growth 5Y

3.1%

Net income growth

7.92%

Net income growth (Q)

191.77%

Net income growth (QoQ)

1.22%

Net income growth 3Y

18.15%

Net income growth 5Y

-7.45%

Net income growth quarters

Net income growth years

OCF growth

95.3%

OCF growth (Q)

234.48%

OCF growth (QoQ)

49.33%

OCF growth 10Y

4.54%

OCF growth 3Y

-10.36%

OCF growth 5Y

0.83%

Operating income growth

30.17%

Operating income growth (Q)

47.59%

Operating income growth 3Y

-5.64%

Operating income growth 5Y

-1.43%

Revenue growth

7.37%

Revenue growth (Q)

7.14%

Revenue growth (QoQ)

5.61%

Revenue growth 10Y

9.49%

Revenue growth 3Y

6.87%

Revenue growth 5Y

8.28%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	ARS -4.5T
Depreciation and amortization	ARS 7T
EBIT	ARS 18T
EBITDA	ARS 24.7T
EPS	ARS 391.37
Financing cash flow	ARS -12.5T
Free cash flow	ARS 17.4T
Free cash flow minus SBC	ARS 16.4T
Gross profit	ARS 83.4T
Income taxes	ARS 1.3T
Investing cash flow	ARS -10.1T
Net borrowing	ARS -8T
Net cash flow	ARS -723B
Net income	ARS 7.2T
Operating cash flow minus SBC	ARS 20.8T
Operating income	ARS 18T
Revenue	ARS 611.3T
Stock-based compensation	ARS 1.1T

Metric

Value

Capital expenditures

ARS -4.5T

Depreciation and amortization

ARS 7T

EBIT

ARS 18T

EBITDA

ARS 24.7T

EPS

ARS 391.37

Financing cash flow

ARS -12.5T

Free cash flow

ARS 17.4T

Free cash flow minus SBC

ARS 16.4T

Gross profit

ARS 83.4T

Income taxes

ARS 1.3T

Investing cash flow

ARS -10.1T

Net borrowing

ARS -8T

Net cash flow

ARS -723B

Net income

ARS 7.2T

Operating cash flow minus SBC

ARS 20.8T

Operating income

ARS 18T

Revenue

ARS 611.3T

Stock-based compensation

ARS 1.1T

Metric	Value
Altman Z-Score	2.43
Book value per share	ARS 92,393.20
Debt / EBITDA	3.87
Debt / equity	0.96
Debt / FCF	6.49
Goodwill	ARS 131.5T
Interest coverage	3.92
Long-term assets	ARS 260.1T
Long-term liabilities	ARS 123.7T
Net cash (debt)	ARS -92.4T
Net cash / market cap	-51.52%
Net debt / EBITDA	3.74
Net debt / equity	0.78
Net debt / FCF	5.3
Piotroski F-Score	7
Property, plant and equipment	ARS 42.5T
Shareholders' equity	ARS 118.4T
Tangible book value	ARS -45.1T
Tangible book value per share	ARS -35,263.87
Total assets	ARS 376T
Total cash	ARS 20.7T
Total debt	ARS 113T
Total liabilities	ARS 257.6T

Metric

Value

Altman Z-Score

2.43

Book value per share

ARS 92,393.20

Debt / EBITDA

3.87

Debt / equity

0.96

Debt / FCF

6.49

Goodwill

ARS 131.5T

Interest coverage

3.92

Long-term assets

ARS 260.1T

Long-term liabilities

ARS 123.7T

Net cash (debt)

ARS -92.4T

Net cash / market cap

-51.52%

Net debt / EBITDA

3.74

Net debt / equity

0.78

Net debt / FCF

5.3

Piotroski F-Score

Property, plant and equipment

ARS 42.5T

Shareholders' equity

ARS 118.4T

Tangible book value

ARS -45.1T

Tangible book value per share

ARS -35,263.87

Total assets

ARS 376T

Total cash

ARS 20.7T

Total debt

ARS 113T

Total liabilities

ARS 257.6T

Metric	Value
Asset turnover	1.61
Current assets	ARS 115.9T
Current liabilities	ARS 133.9T
Current ratio	0.87
Inventory turnover	20.32
Net working capital	ARS -32.3T
Quick ratio	0.62
Working capital	ARS -17.3T
Working capital turnover	-40,474.94

Metric

Value

Asset turnover

1.61

Current assets

ARS 115.9T

Current liabilities

ARS 133.9T

Current ratio

0.87

Inventory turnover

20.32

Net working capital

ARS -32.3T

Quick ratio

0.62

Working capital

ARS -17.3T

Working capital turnover

-40,474.94

Metric	Value
Buyback yield / dilution	-1.19%
Dividend growth	36.71%
Dividend growth years	1
Dividend payment date	2026-11-02
Dividend payment years	3
Dividend payout frequency	Quarterly
Dividend per share	ARS 187.75
Dividend yield	1.88%
Ex-dividend date	2026-10-22
Last dividend	ARS 67.68
Payout ratio	69.86%
Shareholder yield	0.69%

Metric

Value

Buyback yield / dilution

-1.19%

Dividend growth

36.71%

Dividend growth years

Dividend payment date

2026-11-02

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

ARS 187.75

Dividend yield

1.88%

Ex-dividend date

2026-10-22

Last dividend

ARS 67.68

Payout ratio

69.86%

Shareholder yield

0.69%

Metric	Value
150-day SMA	ARS 9,492.27
1D price change	-2.72%
1M price change	3.84%
1M total return	4.54%
1W price change	-0.3%
1W total return	0.37%
1Y price change	17.1%
1Y return CAGR	19.51%
1Y total return	19.49%
20-day SMA	ARS 9,728.00
200-day SMA	ARS 9,049.35
3M price change	-12.36%
3M total return	-11.77%
50-day SMA	ARS 9,821.90
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 12,000.00
52-week high date	2026-07-01
52-week low	ARS 6,585.00
52-week low date	2026-03-26
6M price change	30.89%
6M total return	32.25%
All-time high	ARS 12,000.00
All-time high date	2026-07-01
All-time low	ARS 3,390.00
All-time low date	2024-12-20
Average true range (ATR)	ARS 273.09
Average volume	12.9K
Change from 52-week high	-16.67%
Change from 52-week low	51.86%
Change from all-time high	-16.67%
Change from all-time low	194.99%
Change from open	-3.29%
Day's gap	0.58%
Dollar volume	ARS 103.9M
High price	ARS 10,390.00
Low price	ARS 10,000.00
Monthly RSI	66.34
Open price	ARS 10,340.00
Position in 52-week range	0%
Previous close	ARS 10,280.00
Price vs 150-day SMA	5.35%
Price vs 20-day SMA	2.8%
Price vs 200-day SMA	10.51%
Price vs 50-day SMA	1.81%
Relative volume	0.8
RSI	53.95
Sharpe ratio	0.7
Sortino ratio	1.18
Volume	10.4K
Weekly RSI	54.19
YTD price change	34.59%
YTD total return	37.34%

Metric

Value

150-day SMA

ARS 9,492.27

1D price change

-2.72%

1M price change

3.84%

1M total return

4.54%

1W price change

-0.3%

1W total return

0.37%

1Y price change

17.1%

1Y return CAGR

19.51%

1Y total return

19.49%

20-day SMA

ARS 9,728.00

200-day SMA

ARS 9,049.35

3M price change

-12.36%

3M total return

-11.77%

50-day SMA

ARS 9,821.90

50-day SMA vs 200-day SMA

50over200

52-week high

ARS 12,000.00

52-week high date

2026-07-01

52-week low

ARS 6,585.00

52-week low date

2026-03-26

6M price change

30.89%

6M total return

32.25%

All-time high

ARS 12,000.00

All-time high date

2026-07-01

All-time low

ARS 3,390.00

All-time low date

2024-12-20

Average true range (ATR)

ARS 273.09

Average volume

12.9K

Change from 52-week high

-16.67%

Change from 52-week low

51.86%

Change from all-time high

-16.67%

Change from all-time low

194.99%

Change from open

-3.29%

Day's gap

0.58%

Dollar volume

ARS 103.9M

High price

ARS 10,390.00

Low price

ARS 10,000.00

Monthly RSI

66.34

Open price

ARS 10,340.00

Position in 52-week range

Previous close

ARS 10,280.00

Price vs 150-day SMA

5.35%

Price vs 20-day SMA

2.8%

Price vs 200-day SMA

10.51%

Price vs 50-day SMA

1.81%

Relative volume

0.8

RSI

53.95

Sharpe ratio

0.7

Sortino ratio

1.18

Volume

10.4K

Weekly RSI

54.19

YTD price change

34.59%

YTD total return

37.34%

Metric	Value
Float	1.3B
Shares change (QoQ)	0.63%
Shares change (YoY)	1.19%
Shares held by insiders	0.09%
Shares held by institutions	90.42%
Short ratio	2 days

Metric

Value

Float

1.3B

Shares change (QoQ)

0.63%

Shares change (YoY)

1.19%

Shares held by insiders

0.09%

Shares held by institutions

90.42%

Short ratio

2 days

BCBA/CVS (BCBA/CVS)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/CVS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/CVS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/CVS

Frequently asked questions